MiMedx Group

MiMedx Group was incorporated on February 28, 2008. Its initial assets consisted of our HydroFix® and CollaFixTM technology platforms. On January 5, 2011, the company acquired all of the outstanding equity interests in Surgical Biologics, LLC, and subsequently consolidated the corporate offices and operating facilities in Kennesaw, Georgia. This strategic acquisition brought together amnion tissue processing technology with MiMedx®'s experienced management team and extensive distribution network in order to position the company for market opportunities across multiple areas of medicine. Surgical Biologics developed allografts and other products processed from human amniotic membrane that can be used for a wide range of medical applications, including ocular surface repair, gum repair, wound care, nerve and tendon protection, spine surgery, burn treatment, and many other types of procedures that require the repair of a patient’s integumental (native) tissue.
Type
Public
HQ
Marietta, US
Employees
550 (est)
MiMedx Group is headquartered in Marietta, US

Key People at MiMedx Group

Thomas H. Hochuli

Thomas H. Hochuli

Vice President of Operations
Parker H. Petit

Parker H. Petit

CEO & Chairman
William C. Taylor

William C. Taylor

President and Chief Operating Officer
Frank Burrows

Frank Burrows

Vice President of Corporate Strategy
Rebeccah J. C. Brown

Rebeccah J. C. Brown

Vice President of Product Development, Regulatory Affairs, and Quality Assurance
Deborah Dean

Deborah Dean

Executive Vice President

MiMedx Group Locations

Marietta, US

MiMedx Group Metrics

MiMedx Group Summary

Market capitalization

$982 M

Closing share price

$9.21
MiMedx Group's latest market capitalization is $982 M.

MiMedx Group Market Value History

MiMedx Group Online Presence

MiMedx Group News

MiMedx Group Company Life